We are live on ! Find out more
Cerity Partners

Cerity Partners Portfolio holdings

AUM $70.8B
1-Year Est. Return 21.68%
This Fund
S&P 500
This Quarter Est. Return
-14.03%
1 Year Est. Return
+21.68%
3 Year Est. Return
+64.34%
5 Year Est. Return
+67.23%
10 Year Est. Return
AUM
$9.05B
AUM Growth
+$2.61B
Cap. Flow
+$2.57B
Cap. Flow %
28.36%
Top 10 Hldgs %
33.38%
Holding
1,260
New
320
Increased
653
Reduced
168
Closed
80

Sector Composition

Rank Sector Weight
1 Technology 12.55%
2 Healthcare 8.3%
3 Financials 7.53%
4 Industrials 6.18%
5 Consumer Discretionary 4.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XLE icon
301
State Street Energy Select Sector SPDR ETF
XLE
$39.5B
$3.61M 0.04%
100,846
-5,978
-6% -$240K
GNR icon
302
State Street SPDR S&P Global Natural Resources ETF
GNR
$4.75B
$3.6M 0.04%
69,214
+3,376
+5% +$203K
DBEF icon
303
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
$9.13B
$3.59M 0.04%
103,165
+9,542
+10% +$350K
MNRO icon
304
Monro
MNRO
$525M
$3.51M 0.04%
81,912
+60
+0.1% +$2.68K
BNDX icon
305
Vanguard Total International Bond ETF
BNDX
$82B
$3.46M 0.04%
69,811
-8,422
-11% -$425K
EW icon
306
Edwards Lifesciences
EW
$47.6B
$3.39M 0.04%
+35,604
New +$3.69M
GSBD icon
307
Goldman Sachs BDC
GSBD
$975M
$3.37M 0.04%
200,384
-13,245
-6% -$244K
SYY icon
308
Sysco
SYY
$39.7B
$3.32M 0.04%
39,218
+3,201
+9% +$268K
CNC icon
309
Centene
CNC
$31.3B
$3.3M 0.04%
38,953
-1,741
-4% -$145K
DFAC icon
310
Dimensional US Core Equity 2 ETF
DFAC
$47.5B
$3.28M 0.04%
140,662
+15,763
+13% +$399K
NVS icon
311
Novartis
NVS
$295B
$3.27M 0.04%
38,719
+14,764
+62% +$1.3M
EXC icon
312
Exelon
EXC
$48.6B
$3.27M 0.04%
72,158
+5,178
+8% +$243K
TECH icon
313
Bio-Techne
TECH
$11.2B
$3.27M 0.04%
37,708
+1,848
+5% +$173K
GM icon
314
General Motors
GM
$74.7B
$3.27M 0.04%
102,951
+10,037
+11% +$377K
PGR icon
315
Progressive
PGR
$124B
$3.26M 0.04%
28,043
+5,767
+26% +$654K
RSP icon
316
Invesco S&P 500 Equal Weight ETF
RSP
$96.1B
$3.25M 0.04%
24,222
-370
-2% -$54.1K
WM icon
317
Waste Management
WM
$95.9B
$3.19M 0.04%
20,860
+8,349
+67% +$1.31M
OBDC icon
318
Blue Owl Capital
OBDC
$5.35B
$3.17M 0.04%
257,320
-40,727
-14% -$558K
AON icon
319
Aon
AON
$77.3B
$3.16M 0.04%
11,729
+2,803
+31% +$806K
DAR icon
320
Darling Ingredients
DAR
$9.93B
$3.16M 0.03%
52,859
+18,231
+53% +$1.38M
BIP icon
321
Brookfield Infrastructure Partners
BIP
$18.8B
$3.1M 0.03%
81,064
+74,387
+1,114% +$3.06M
GSK icon
322
GSK
GSK
$103B
$3.1M 0.03%
56,889
+9,820
+21% +$542K
CDW icon
323
CDW
CDW
$17.1B
$3.09M 0.03%
19,586
-312
-2% -$52.4K
DES icon
324
WisdomTree US SmallCap Dividend Fund
DES
$2.19B
$3.05M 0.03%
+108,015
New +$3.24M
AMLP icon
325
Alerian MLP ETF
AMLP
$13B
$3.04M 0.03%
88,155
+68,368
+346% +$2.62M

Similar funds

Cerity Partners's Q2 2022 Portfolio in Review

As of Q2 2022, Cerity Partners held 1,260 positions worth $9.05B, up 41% from $6.44B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Cerity Partners deployed $2.57B of net new capital in Q2 2022, opening 320 new positions and adding to 653 existing holdings. Its largest new stake was Invesco QQQ Trust: 244,839 shares worth $68.7M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 15% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Vanguard FTSE All-World ex-US ETF, an estimated $27.6M trimmed.

  • Cerity Partners's largest Q2 2022 buy was Invesco QQQ Trust: 244,839 shares worth $68.7M.
  • Cerity Partners added most to Apple in Q2 2022, an estimated $143M increase.
  • Cerity Partners's biggest Q2 2022 reduction was Vanguard FTSE All-World ex-US ETF, cutting an estimated $27.6M.
  • Cerity Partners fully exited State Street SPDR S&P 500 ETF Trust in Q2 2022, selling an estimated $653M.
  • Cerity Partners's ten largest holdings make up 33% of its $9.05B portfolio in Q2 2022.
  • Cerity Partners opened 320 new positions and closed 80 in Q2 2022.
  • Cerity Partners's portfolio value rose 41% quarter-over-quarter to $9.05B.

Based on Cerity Partners's 13F filing for Q2 2022, filed 10 Aug 2022.